Panchal, M Singh, S Rodriguez-Villegas, E
Objectives: To conduct an independent study investigating how adults perceive the usability, and functionality of the ”NHS COVID-19” app. This study aims to highlight strengths, and provide recommendations to improve adoption of future contact tracing developments. Design: A 60-item, anonymous online questionnaire, disseminated through social media...
Kamal, F Kumar, S Edwards, MR Veselkov, K Belluomo, I Kebadze, T Romano, A Trujillo-Torralbo, M-B Shahridan Faiez, T Walton, R
...
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a condition punctuated by acute exacerbations commonly triggered by viral and/or bacterial infection. Early identification of exacerbation trigger is important to guide appropriate therapy but currently available tests are slow and imprecise. Volatile organic compounds (VOCs) can be detect...
Neves, AL Li, E Gupta, PP Fontana, G Darzi, A
Background: Telemedicine, once defined merely as the treatment of certain conditions remotely, has now often been supplanted in use by broader terms such as ‘virtual care’, in recognition of its increasing capability to deliver a diverse range of healthcare services from afar. With the unexpected onset of COVID-19, virtual care (e.g., telephone, vi...
Nugawela, MD Gurudas, S Prevost, AT Mathur, R Robson, J Hanif, W Majeed, A Sivaprasad, S
There is little data on ethnic differences in incidence of DR and sight threatening DR (STDR) in the United Kingdom. We aimed to determine ethnic differences in the development of DR and STDR and to identify risk factors of DR and STDR in people with incident or prevalent type II diabetes (T2DM). We used electronic primary care medical records of p...
Saxena, S Skirrow, H Wighton, K
Taniguchi, Hiroya; Yoshino, Takayuki; Yamaguchi, Kensei; Yamazaki, Kentaro; Nixon, Andrew B; Tabernero, Josep; Van Cutsem, Eric; 3840; Robling, Kim R; Abada, Paolo B; Hozak, Rebecca R;
...
BACKGROUND: Vascular endothelial growth factor (VEGF)-D was identified as a potential predictive biomarker for ramucirumab efficacy in second-line metastatic colorectal cancer using a research use only (RUO) assay. We describe results with a new assay for detecting VEGF-D in human plasma. METHODS: In RAISE (Clinical Trial Registration: NCT01183780)...
Flaxman, A Marchevsky, NG Jenkin, D Aboagye, J Aley, PK Angus, B Belij-Rammerstorfer, S Bibi, S Bittaye, M Cappuccini, F
...
Background COVID-19 vaccine supply shortages are causing concerns about compromised immunity in some countries as the interval between the first and second dose becomes longer. Conversely, countries with no supply constraints are considering administering a third dose. We assessed the persistence of immunogenicity after a single dose of ChAdOx1 nCo...
collaborative, covidsurg collaborative, globalsurg
SARS-CoV-2 has been associated with an increased rate of venous thromboembolism in critically ill patients. Since surgical patients are already at higher risk of venous thromboembolism than general populations, this study aimed to determine if patients with peri-operative or prior SARS-CoV-2 were at further increased risk of venous thromboembolism....
Liu, X Shaw, RH Stuart, ASV Greenland, M Aley, PK Andrews, NJ Cameron, JC Charlton, S Clutterbuck, EA Collins, AM
...
BACKGROUND: Use of heterologous prime-boost COVID-19 vaccine schedules could facilitate mass COVID-19 immunisation. However, we have previously reported that heterologous schedules incorporating an adenoviral vectored vaccine (ChAdOx1 nCoV-19, AstraZeneca; hereafter referred to as ChAd) and an mRNA vaccine (BNT162b2, Pfizer-BioNTech; hereafter refe...
Verhamme, Peter; 2766; Yi, B Alexander; Segers, Annelise; Salter, Janeen; Bloomfield, Daniel; Buller, Harry R; Raskob, Gary E; Weitz, Jeffrey I;
BACKGROUND: The role of factor XI in the pathogenesis of postoperative venous thromboembolism is uncertain. Abelacimab is a monoclonal antibody that binds to factor XI and locks it in the zymogen (inactive precursor) conformation. METHODS: In this open-label, parallel-group trial, we randomly assigned 412 patients who were undergoing total knee art...